Oleanolic acid combined with aspirin plays antitumor roles in colorectal cancer via the Akt/NFκB/IκBα/COX2 pathway
2024

Oleanolic Acid and Aspirin Together Fight Colorectal Cancer

publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhou Yulv, Lin Shengnan, Zhong Xinzhu, Huang Fang, Huang Jinxiang

Primary Institution: Sanming First Hospital, Affiliated Hospital of Fujian Medical University

Hypothesis

Can oleanolic acid combined with aspirin enhance the anticancer effects of aspirin in colorectal cancer treatment?

Conclusion

The combination of oleanolic acid and aspirin significantly inhibits the growth and invasion of colorectal cancer cells and promotes apoptosis.

Supporting Evidence

  • Oleanolic acid and aspirin together inhibit the proliferation of colorectal cancer cells.
  • The combination treatment induces S-phase arrest in cancer cells.
  • Cellular experiments showed that the combination enhances apoptosis in colorectal cancer cells.
  • Network pharmacology identified key signaling pathways involved in the treatment effects.
  • The study provides a theoretical basis for developing aspirin derivatives based on oleanolic acid.

Takeaway

Mixing oleanolic acid with aspirin can help fight colon cancer better than using aspirin alone.

Methodology

The study used network pharmacology, molecular docking, and in vitro experiments to assess the effects of oleanolic acid and aspirin on colorectal cancer cells.

Limitations

The study primarily focused on in vitro experiments, and further in vivo studies are needed to validate the findings.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41420-024-02223-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication